Organon & Co. Files 8-K on Financials and Operations

Ticker: OGN · Form: 8-K · Filed: May 1, 2025 · CIK: 1821825

Organon & CO. 8-K Filing Summary
FieldDetail
CompanyOrganon & CO. (OGN)
Form Type8-K
Filed DateMay 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, operations, disclosure

TL;DR

Organon filed an 8-K on May 1st detailing financial results and other key company events.

AI Summary

Organon & Co. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition. The filing also includes disclosures related to Regulation FD and other events, along with financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 30 Hudson Street, Floor 33, Jersey City, NJ.

Why It Matters

This 8-K filing provides crucial updates on Organon & Co.'s financial performance and operational status, which are important for investors to assess the company's current health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial information and does not appear to contain any immediate negative news or significant changes.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates it pertains to 'Results of Operations and Financial Condition' but does not detail specific figures within the provided text.

What is the significance of the 'Regulation FD Disclosure' item?

This indicates that the company is making disclosures that are intended to be broadly disseminated to the public, preventing selective disclosure of material non-public information.

What does 'Other Events' typically cover in an 8-K filing?

This item is used to report material events that the company deems important enough to report on Form 8-K but do not fit into other specific categories.

When was this Form 8-K filed with the SEC?

The filing was made on May 1, 2025.

What is Organon & Co.'s primary industry classification?

Organon & Co. is classified under 'PHARMACEUTICAL PREPARATIONS' with the Standard Industrial Classification code [2834].

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding Organon & Co. (OGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing